Cargando…
Chitosan–alginate BSA-gel-capsules for local chemotherapy against drug-resistant breast cancer
BACKGROUND AND OBJECT: Polyelectrolyte microcapsule is a promising candidate for multifunctional drug delivery system. However, the lack of reports about animal experiments have greatly slowed down their development for drug delivery. We engineered biodegradable chitosan–alginate polyelectrolyte mul...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5914552/ https://www.ncbi.nlm.nih.gov/pubmed/29719378 http://dx.doi.org/10.2147/DDDT.S158001 |
_version_ | 1783316715480809472 |
---|---|
author | Shen, Haijun Li, Fang Wang, Dongxia Yang, Zhihan Yao, Chunfang Ye, Yang Wang, Xiaona |
author_facet | Shen, Haijun Li, Fang Wang, Dongxia Yang, Zhihan Yao, Chunfang Ye, Yang Wang, Xiaona |
author_sort | Shen, Haijun |
collection | PubMed |
description | BACKGROUND AND OBJECT: Polyelectrolyte microcapsule is a promising candidate for multifunctional drug delivery system. However, the lack of reports about animal experiments have greatly slowed down their development for drug delivery. We engineered biodegradable chitosan–alginate polyelectrolyte multilayer capsule filled with bovine serum albumin gel (BSA-gel-capsule). Herein, we demonstrated their applicability for local chemotherapy, a means of treating local or regional malignancies by direct administration of anti-tumor agents to tumor sites. METHOD: Doxorubicin (DOX) was loaded in BSA-gel-capsules and DOX-resistant cell line (MCF-7/ADR cells) was employed for antitumor studies in vitro. The cytotoxicity, cellular uptake and distribution of DOX from BSA-gel-capsules were studied. Afterwards, MCF-7/ADR xenografts tumor model was established in nude mice. The in vivo antitumor efficacy of DOX-loaded BSA-gel-capsules by intratumor injection was then evaluated. RESULT: Compared with free DOX, more effective cytotoxicity against MCF-7/ADR cells after treatment with DOX-loaded BSA-gel-capsules was revealed, demonstrating the positive reversal effect on drug-resistance. Thereafter, the more cellular uptake and nucleus distribution of DOX from BSA-gel-capsules in MCF-7/ADR cells provided convincing explanation for the reversal effect. DOX-loaded BSA-gel-capsules displayed remarkably more antitumor efficacy than free DOX in MCF-7/ADR cell-xenografted mice. Finally, the high DOX accumulation and prolonged retention in tumor site after local administration of DOX-loaded BSA-gel-capsules was demonstrated, displaying the unique advantages of BSA-gel-capsules for local chemotherapy. CONCLUSION: These findings indicate that DOX-loaded BSA-gel-capsules should be considered a potential candidate for the treatment of drug-resistant breast cancer. This paper provides a feasibility for the local chemotherapy of polyelectrolyte microcapsules, which will be a big step towards their application as drug delivery vehicles. |
format | Online Article Text |
id | pubmed-5914552 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-59145522018-05-01 Chitosan–alginate BSA-gel-capsules for local chemotherapy against drug-resistant breast cancer Shen, Haijun Li, Fang Wang, Dongxia Yang, Zhihan Yao, Chunfang Ye, Yang Wang, Xiaona Drug Des Devel Ther Original Research BACKGROUND AND OBJECT: Polyelectrolyte microcapsule is a promising candidate for multifunctional drug delivery system. However, the lack of reports about animal experiments have greatly slowed down their development for drug delivery. We engineered biodegradable chitosan–alginate polyelectrolyte multilayer capsule filled with bovine serum albumin gel (BSA-gel-capsule). Herein, we demonstrated their applicability for local chemotherapy, a means of treating local or regional malignancies by direct administration of anti-tumor agents to tumor sites. METHOD: Doxorubicin (DOX) was loaded in BSA-gel-capsules and DOX-resistant cell line (MCF-7/ADR cells) was employed for antitumor studies in vitro. The cytotoxicity, cellular uptake and distribution of DOX from BSA-gel-capsules were studied. Afterwards, MCF-7/ADR xenografts tumor model was established in nude mice. The in vivo antitumor efficacy of DOX-loaded BSA-gel-capsules by intratumor injection was then evaluated. RESULT: Compared with free DOX, more effective cytotoxicity against MCF-7/ADR cells after treatment with DOX-loaded BSA-gel-capsules was revealed, demonstrating the positive reversal effect on drug-resistance. Thereafter, the more cellular uptake and nucleus distribution of DOX from BSA-gel-capsules in MCF-7/ADR cells provided convincing explanation for the reversal effect. DOX-loaded BSA-gel-capsules displayed remarkably more antitumor efficacy than free DOX in MCF-7/ADR cell-xenografted mice. Finally, the high DOX accumulation and prolonged retention in tumor site after local administration of DOX-loaded BSA-gel-capsules was demonstrated, displaying the unique advantages of BSA-gel-capsules for local chemotherapy. CONCLUSION: These findings indicate that DOX-loaded BSA-gel-capsules should be considered a potential candidate for the treatment of drug-resistant breast cancer. This paper provides a feasibility for the local chemotherapy of polyelectrolyte microcapsules, which will be a big step towards their application as drug delivery vehicles. Dove Medical Press 2018-04-19 /pmc/articles/PMC5914552/ /pubmed/29719378 http://dx.doi.org/10.2147/DDDT.S158001 Text en © 2018 Shen et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Shen, Haijun Li, Fang Wang, Dongxia Yang, Zhihan Yao, Chunfang Ye, Yang Wang, Xiaona Chitosan–alginate BSA-gel-capsules for local chemotherapy against drug-resistant breast cancer |
title | Chitosan–alginate BSA-gel-capsules for local chemotherapy against drug-resistant breast cancer |
title_full | Chitosan–alginate BSA-gel-capsules for local chemotherapy against drug-resistant breast cancer |
title_fullStr | Chitosan–alginate BSA-gel-capsules for local chemotherapy against drug-resistant breast cancer |
title_full_unstemmed | Chitosan–alginate BSA-gel-capsules for local chemotherapy against drug-resistant breast cancer |
title_short | Chitosan–alginate BSA-gel-capsules for local chemotherapy against drug-resistant breast cancer |
title_sort | chitosan–alginate bsa-gel-capsules for local chemotherapy against drug-resistant breast cancer |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5914552/ https://www.ncbi.nlm.nih.gov/pubmed/29719378 http://dx.doi.org/10.2147/DDDT.S158001 |
work_keys_str_mv | AT shenhaijun chitosanalginatebsagelcapsulesforlocalchemotherapyagainstdrugresistantbreastcancer AT lifang chitosanalginatebsagelcapsulesforlocalchemotherapyagainstdrugresistantbreastcancer AT wangdongxia chitosanalginatebsagelcapsulesforlocalchemotherapyagainstdrugresistantbreastcancer AT yangzhihan chitosanalginatebsagelcapsulesforlocalchemotherapyagainstdrugresistantbreastcancer AT yaochunfang chitosanalginatebsagelcapsulesforlocalchemotherapyagainstdrugresistantbreastcancer AT yeyang chitosanalginatebsagelcapsulesforlocalchemotherapyagainstdrugresistantbreastcancer AT wangxiaona chitosanalginatebsagelcapsulesforlocalchemotherapyagainstdrugresistantbreastcancer |